Tasly Pharmaceutical （600535） Mutual Empowerment of Tasly & CR Sanjiu， Eyeing Innovation

Equity Research Report Tasly Pharmaceutical (600535 CH) Mutual Empowerment of Tasly & CR Sanjiu, Eyeing Innovation Huatai ResearchEvent Comment 13 August 2024 | China (Mainland)Traditional Chinese Medicine Controlling shareholder transferring 28% of share capital to CR Sanjiu Tasly has announced that its controlling shareholder, Tasly Group, along with its concerted action partners, plans to transfer about 418mn shares (accounting for 28% of total share capital) to CR Sanjiu at a transfer price of c RMB6,21 ...